Patents Assigned to JYANT TECHNOLOGIES
  • Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
    Patent number: 9233120
    Abstract: Methods for prevention or inhibition of the growth or metastasis of cancer cells in a subject are disclosed. One method comprises the step of administering to the subject a therapeutically effective amount of an antibody to the chemokine CCL25 and/or the chemokine receptor CCR9. Another method comprises the step of administering to the subject a therapeutically effective amount of an expression vector that expresses an antibody to the chemokine CCL25 and/or the chemokine receptor CCR9.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: January 12, 2016
    Assignee: JYANT TECHNOLOGIES
    Inventors: James W. Lillard, Shailesh Singh, Rajesh Singh